BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1986975)

  • 1. Endometrial antibodies versus CA-125 for the detection of endometriosis.
    Wild RA; Hirisave V; Bianco A; Podczaski ES; Demers LM
    Fertil Steril; 1991 Jan; 55(1):90-4. PubMed ID: 1986975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the source of elevated serum levels of CA 125 in patients with endometriosis?
    Fedele L; Arcaini L; Baglioni A; Bianchi S; Menard S
    Eur J Obstet Gynecol Reprod Biol; 1989 Dec; 33(3):247-52. PubMed ID: 2689251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies associated with endometriosis: can their detection predict presence of the disease?
    Wild RA; Hirisave V; Podczaski ES; Coulam C; Shivers CA; Satyaswaroop PG
    Obstet Gynecol; 1991 Jun; 77(6):927-31. PubMed ID: 2030870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An endometrial antibody assay in the clinical diagnosis and management of endometriosis.
    Chihal HJ; Mathur S; Holtz GL; Williamson HO
    Fertil Steril; 1986 Sep; 46(3):408-11. PubMed ID: 3743793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiendometrial antibodies in patients with endometriosis.
    Wild RA; Shivers CA
    Am J Reprod Immunol Microbiol; 1985 Jul; 8(3):84-6. PubMed ID: 3895994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity to endometrium and ovary in endometriosis.
    Mathur S; Peress MR; Williamson HO; Youmans CD; Maney SA; Garvin AJ; Rust PF; Fudenberg HH
    Clin Exp Immunol; 1982 Nov; 50(2):259-66. PubMed ID: 6759000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of CA125 (carbon hydrate tumor-associated antigen) and endometrial antibodies for the detections of endometriosis].
    Yang F; Fang AH; Gu RF
    Zhonghua Fu Chan Ke Za Zhi; 1994 Mar; 29(3):147-9, 189. PubMed ID: 8082430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial immunofluorescence associated with endometriosis and pelvic inflammatory disease.
    Kreiner D; Fromowitz FB; Richardson DA; Kenigsberg D
    Fertil Steril; 1986 Aug; 46(2):243-6. PubMed ID: 3525236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis between uterine myoma and endometriosis using CA 125 as a new tumor marker of ovarian carcinoma.
    Takahashi K; Kijima S; Yoshino K; Shibukawa T; Murao F; Kitao M
    Asia Oceania J Obstet Gynaecol; 1986 Mar; 12(1):99-103. PubMed ID: 3459417
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum CA 125 levels in patients with endometriosis: changes in CA 125 levels during menstruation.
    Masahashi T; Matsuzawa K; Ohsawa M; Narita O; Asai T; Ishihara M
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):328-31. PubMed ID: 3165507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormally high values of CA 125 and CA 19-9 in women with benign tumors.
    Nagata H; Takahashi K; Yamane Y; Yoshino K; Shibukawa T; Kitao M
    Gynecol Obstet Invest; 1989; 28(3):165-8. PubMed ID: 2680806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-endometrial and anti-endothelial auto-antibodies in women with endometriosis.
    Fernández-Shaw S; Hicks BR; Yudkin PL; Kennedy S; Barlow DH; Starkey PM
    Hum Reprod; 1993 Feb; 8(2):310-5. PubMed ID: 8473439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial localization of antiendometrial antibodies associated with endometriosis.
    Wild RA; Satyaswaroop PG; Shivers AC
    Am J Reprod Immunol Microbiol; 1987 Feb; 13(2):62-5. PubMed ID: 2438953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA 125 in serum, peritoneal fluid, active lesions, and endometrium of patients with endometriosis.
    Fedele L; Vercellini P; Arcaini L; da Dalt MG; Candiani GB
    Am J Obstet Gynecol; 1988 Jan; 158(1):166-70. PubMed ID: 3422132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum CA-125 levels in women with endometriosis.
    Grover S; Koh H
    Aust N Z J Obstet Gynaecol; 1990 Aug; 30(3):279-80. PubMed ID: 2256870
    [No Abstract]   [Full Text] [Related]  

  • 16. Gonadotrophin releasing hormone agonist (buserelin) in the treatment of endometriosis: changes in the extent of the disease and in CA 125 serum levels after 6-month therapy.
    Marana R; Muzii L; Muscatello P; Lanzone A; Caruso A; Dell'Acqua S; Mancuso S
    Br J Obstet Gynaecol; 1990 Nov; 97(11):1016-9. PubMed ID: 2147564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CA-125 levels in the diagnosis and management of endometriosis.
    Lanzone A; Marana R; Muscatello R; Fulghesu AM; Dell'Acqua S; Caruso A; Mancuso S
    J Reprod Med; 1991 Aug; 36(8):603-7. PubMed ID: 1834843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum CA 125 as a marker for patients with external endometriosis.
    Takahashi K; Kijima S; Yoshino K; Shibukawa T; Kitao M
    Int J Fertil; 1989; 34(2):143-8. PubMed ID: 2565317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of CA-125 tumor marker in endometrial carcinoma.
    Kukura V; Zaninović I; Hrdina B
    Gynecol Oncol; 1990 Jun; 37(3):388-9. PubMed ID: 2351323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunological aspects of endometriosis].
    Kuhn U
    Gynakologe; 1990 Jun; 23(3):135-9. PubMed ID: 2201598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.